Search

everythinglearnresearchcommunity

for

Search:↓

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Biologics for severe asthma have known side effects, but some new risks need more study.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Hair oils can worsen seborrheic dermatitis in black patients.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Hair follicles can be kept in RNAlater® at cool or room temperature for a week without harming RNA quality.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Many people in Fez-Meknes use potentially toxic plants for various health and cosmetic purposes, but more research is needed to ensure their safety.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Objective assessment is needed to accurately determine medication use and adherence.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

Smoking doubles the risk of blindness, and physical exercise helps dyslexic children read better.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Injecting platelet-rich plasma into the scalp stimulates hair growth, increases hair density, and treats hair loss effectively with minimal side effects.

Platelet-rich plasma (PRP) injections effectively treat hair loss and thinning in both men and women, with high satisfaction and no major side effects.